Investor relations professional @ Buchan. Covering med tech, healthcare and biotech and tech. Living and loving the crazy juggle of life with two little ones.
Melbourne, Victoria
Joined September 2012
- Tweets89
- Following184
- Followers133
- Likes42
Kyahn Williamson retweeted
R&D Tax Incentive bill to be deferred until further examination - great outcome for local innovation and biotech companies led by @ausbiotech @MedicinesAus & @biomelb biotechdispatch.com.au/news/… #ausbiotech #ausbiz
Kyahn Williamson retweeted
Huge story this. One of Australia's hottest startups Unlockd has had to pull out of an imminent IPO to fight for survival after Google said it was banning its apps from the Play Store and AdMob (anti-competitive move?!) afr.com/technology/unlockd-p… #startupaus
Kyahn Williamson retweeted
So proud of the wonderful team @BuchanWE and our amazing clients. We just won Agency of the Year @mumbrella #CommsCon
Kyahn Williamson retweeted
Telix Pharmaceuticals and Radboud University Medical Centre Conclude Clinical Collaboration Agreement bit.ly/2IokqxY
Kyahn Williamson retweeted
McDonald's Hands New Consumer Tech Brief To WE Communications bit.ly/2zchpyf
Kyahn Williamson retweeted
Nice Livewire write-up on Telix $TLX - Thanks for the Christmas Present!
livewiremarkets.com/wires/li…
Kyahn Williamson retweeted
Distruptor or enabler. Whatever you think the latest fintech to hit the @ASX @_SelfWealth is the hot talking point of broking and self directed investors. If you missed out on IPO jump in now.
Kyahn Williamson retweeted
$VHT Clearance strengthens position in Taiwan 670,000 market. High breast cancer occurrence and use of detection tech. RBS target price 81c
Kyahn Williamson retweeted
Meet our new CEO. A punchy interview by @ScottPowerSays at @morgansAU. Welcome Dr. Wilson!
soundcloud.com/morgans-finan… @BuchanIR @Factor_Tx
Kyahn Williamson retweeted
As part of the $ASX CEO sessions, @Factor_Tx NED Dr Chris Behrenbruch discuses FTT's trials & future potential bit.ly/2slklSB $FTT
Kyahn Williamson retweeted
.@Finnewsnetwork discusses Visioneering Technologies Inc (ASX:VTI) recent #IPO w/ CEO Dr Stephen Snowdy bit.ly/2p74YfR #ASX $VTI
Kyahn Williamson retweeted
Women with dense breasts are 4–6 times more likely to develop breast cancer. Know your risk bit.ly/2o8nyWT
Kyahn Williamson retweeted
Congratulations to the team at Reva Medical $RVA on achieving CE Mark for the Fantom bioresorbable coronary scaffold bit.ly/2o3sYCM
Kyahn Williamson retweeted
Visioneering Techonologies, Inc. lists on the ASX – Listing Ceremony pscp.tv/w/a6hLAjFtTUtQcW1lT1…
Kyahn Williamson retweeted
"Australia is already right up there and could be positioned at the front of the bus" #medtech #innovation afr.com/technology/australia…
Kyahn Williamson retweeted
Heard the news? @WEcomms expanding its Asia presence with acquisition of #WATATAWA and #RedBridge. Welcome to the @WE_APAC family @BuchanWE
Kyahn Williamson retweeted
Great segment on our client @AirXpander on @CBS' medical TV show @TheDoctors thedoctorstv.com/articles/38… #ASX #AXP
Kyahn Williamson retweeted
Great to see .@VolparaDensity showcasing the impact of breast density screening in patients #ASX #breastdensity teapaw.org/VolparaDensity/status/…
See how VolparaDensity is being used at @BocaRegional – making a difference to patient lives #breastdensity youtu.be/s6xYfPAlzY4
Kyahn Williamson retweeted
Factor Therapeutics appoints @Teva, ex-@Roche executive, John Michailidis as Non-Executive Director bit.ly/2knUEl7 $FTT @Factor_Tx